India · Delayed Price · Currency is INR Jenburkt Pharmaceuticals Statistics
Total Valuation
BOM:524731 has a market cap or net worth of INR 4.16 billion. The enterprise value is 3.37 billion.
| Market Cap | 4.16B |
| Enterprise Value | 3.37B |
Important Dates
The next estimated earnings date is Tuesday, February 2, 2027.
| Earnings Date | Feb 2, 2027 |
| Ex-Dividend Date | Aug 28, 2026 |
Share Statistics
BOM:524731 has 4.41 million shares outstanding. The number of shares has decreased by -0.02% in one year.
| Current Share Class | 4.41M |
| Shares Outstanding | 4.41M |
| Shares Change (YoY) | -0.02% |
| Shares Change (QoQ) | +0.04% |
| Owned by Insiders (%) | 55.12% |
| Owned by Institutions (%) | 6.30% |
| Float | 1.26M |
Valuation Ratios
The trailing PE ratio is 12.66.
| PE Ratio | 12.66 |
| Forward PE | n/a |
| PS Ratio | 2.43 |
| PB Ratio | 2.03 |
| P/TBV Ratio | 2.03 |
| P/FCF Ratio | 29.44 |
| P/OCF Ratio | 15.64 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.03, with an EV/FCF ratio of 23.84.
| EV / Earnings | 10.25 |
| EV / Sales | 1.97 |
| EV / EBITDA | 8.03 |
| EV / EBIT | 8.61 |
| EV / FCF | 23.84 |
Financial Position
The company has a current ratio of 5.09, with a Debt / Equity ratio of 0.01.
| Current Ratio | 5.09 |
| Quick Ratio | 4.30 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.05 |
| Debt / FCF | 0.16 |
| Interest Coverage | 94.41 |
Financial Efficiency
Return on equity (ROE) is 16.95% and return on invested capital (ROIC) is 21.48%.
| Return on Equity (ROE) | 16.95% |
| Return on Assets (ROA) | 11.02% |
| Return on Invested Capital (ROIC) | 21.48% |
| Return on Capital Employed (ROCE) | 18.54% |
| Weighted Average Cost of Capital (WACC) | 6.46% |
| Revenue Per Employee | 2.14M |
| Profits Per Employee | 410,434 |
| Employee Count | 801 |
| Asset Turnover | 0.77 |
| Inventory Turnover | 2.78 |
Taxes
In the past 12 months, BOM:524731 has paid 102.38 million in taxes.
| Income Tax | 102.38M |
| Effective Tax Rate | 23.75% |
Stock Price Statistics
The stock price has decreased by -24.97% in the last 52 weeks. The beta is 0.40, so BOM:524731's price volatility has been lower than the market average.
| Beta (5Y) | 0.40 |
| 52-Week Price Change | -24.97% |
| 50-Day Moving Average | 956.68 |
| 200-Day Moving Average | 1,047.66 |
| Relative Strength Index (RSI) | 55.77 |
| Average Volume (20 Days) | 302 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:524731 had revenue of INR 1.71 billion and earned 328.76 million in profits. Earnings per share was 74.50.
| Revenue | 1.71B |
| Gross Profit | 1.36B |
| Operating Income | 391.43M |
| Pretax Income | 431.14M |
| Net Income | 328.76M |
| EBITDA | 413.51M |
| EBIT | 391.43M |
| Earnings Per Share (EPS) | 74.50 |
Balance Sheet
The company has 815.11 million in cash and 22.52 million in debt, with a net cash position of 792.59 million or 179.59 per share.
| Cash & Cash Equivalents | 815.11M |
| Total Debt | 22.52M |
| Net Cash | 792.59M |
| Net Cash Per Share | 179.59 |
| Equity (Book Value) | 2.05B |
| Book Value Per Share | 464.29 |
| Working Capital | 971.81M |
Cash Flow
In the last 12 months, operating cash flow was 266.07 million and capital expenditures -124.72 million, giving a free cash flow of 141.35 million.
| Operating Cash Flow | 266.07M |
| Capital Expenditures | -124.72M |
| Depreciation & Amortization | 22.08M |
| Net Borrowing | -7.90M |
| Free Cash Flow | 141.35M |
| FCF Per Share | 32.03 |
Margins
Gross margin is 79.44%, with operating and profit margins of 22.87% and 19.21%.
| Gross Margin | 79.44% |
| Operating Margin | 22.87% |
| Pretax Margin | 25.20% |
| Profit Margin | 19.21% |
| EBITDA Margin | 24.17% |
| EBIT Margin | 22.87% |
| FCF Margin | 8.26% |
Dividends & Yields
This stock pays an annual dividend of 20.70, which amounts to a dividend yield of 2.20%.
| Dividend Per Share | 20.70 |
| Dividend Yield | 2.20% |
| Dividend Growth (YoY) | 15.00% |
| Years of Dividend Growth | 5 |
| Payout Ratio | 28.10% |
| FCF Payout Ratio | 64.63% |
| Buyback Yield | 0.02% |
| Shareholder Yield | 2.21% |
| Earnings Yield | 7.90% |
| FCF Yield | 3.40% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |